- 2 updates
For more updates on this story visit the ITV News Granada website
GSK today confirmed that it will invest more than £500m in the UK across its manufacturing sites to increase production of key active ingredients for its pharmaceutical products and vaccines.
The company announced selection of Ulverston in Cumbria as the location for the first new GSK manufacturing facility to be built in the UK for almost 40 years.
- In total more than £500m of investment confirmed, creating up to 1,000 new jobs.
- Includes £100m investment for GSK manufacturing in Scotland.
Investment will also be made at the company’s two manufacturing sites in Scotland at Montrose and Irvine. In total, it is anticipated these investments will create up to 1,000 new jobs over the lifetime of the projects.